Cullinan Oncology, Inc. (CGEM-Q)
NASDAQ:CGEM
7.77
0.07
(0.91%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await Nvidia
We reiterate this biopharma company focused on oncology therapies, as a TOP PICK. Pilot projects are continuing to advance and they have a growing pipeline of new prospects. It trades under book value, supporting a 14% ROE. Cash reserves are growing, while debt is retired. We recommend maintaining the stop at $8.50, looking to achieve $17.00 -- upside of 36%. Yield 0%
(Analysts’ price target is $29.00)CGEM is a unique pharmaceutical company that collaborates with other developers and academia to develop drugs to help cancer patients. It has six on-going products in its pipeline. It trades below book value, at 6x earnings, and supports a 19% ROE. We like that it is low beta compared to the market. We recommend a stop-loss at $8.50, looking to achieve $17 — upside potential of 50%. Yield 0%
(Analysts’ price target is $28.75)- «
- ‹
- 1
- ›
- »
Cullinan Oncology, Inc.(CGEM-Q) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Cullinan Oncology, Inc.(CGEM-Q) Frequently Asked Questions
What is Cullinan Oncology, Inc. stock symbol?
Cullinan Oncology, Inc. is a American stock, trading under the symbol CGEM-Q on the NASDAQ (CGEM). It is usually referred to as NASDAQ:CGEM or CGEM-Q
Is Cullinan Oncology, Inc. a buy or a sell?
In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.
Is Cullinan Oncology, Inc. a good investment or a top pick?
Cullinan Oncology, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cullinan Oncology, Inc..
Why is Cullinan Oncology, Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Cullinan Oncology, Inc. worth watching?
In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.
What is Cullinan Oncology, Inc. stock price?
On 2025-05-08, Cullinan Oncology, Inc. (CGEM-Q) stock closed at a price of $7.77.
Our PAST TOP PICK with CGEM has triggered its stop at $8.50. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 27%, when combined with previous recommendations.